Ambulatory Surgery Centers are surging nationwide, promising efficiency but driving hidden risks for payors — from aggressive coding to opaque pricing and fewer negotiation options. What was once seen as a cost-saving alternative is now a hotspot for inflated claims.
H.H.C. Group delivers the attorney-led negotiations, clinical reviews, and benchmark-based pricing strategies needed to contain ASC costs and protect your plan.
With more than 14 years at H.H.C. Group, Dr. Roger Hinkson ensures every review is clear, evidence-based, and defensible. His leadership in utilization and independent reviews strengthens quality control, safeguards plan assets and reinforces fairness in patient care.
H.H.C. Group's commitment to detailed oversight delivers the confidence payors need in today's complex claims environment.
Employer health plan costs are projected to rise 10% in 2026, with catastrophic claims and high-cost drugs like GLP-1s and cancer therapies driving the increase. These pressures put self-insured employers, TPAs, and stop-loss carriers at risk of runaway expenses. H.H.C. Group delivers the cost-containment strategies needed to fight back — attorney-led negotiations, PPO partner discounts, bill audits, and reference-based pricing that deliver savings of up to 90%.